Industry

CRISPR-GNDM® platform achieves potent and specific activation of LAMA1 with therapeutic benefit in preclinical models Favorable safety and pharmacodynamics demonstrated in non-human primates TOKYO & WALTHAM, Mass.–(BUSINESS WIRE)–#Crispr–Modalis Therapeutics Corporation (TOKYO: 4883) today announced that its research article titled “Efficient LAMA1 gene activation by epigenome editing as a therapeutic approach for LAMA2-CMD” has been published … [Read more…]

High-Performance, High-Accuracy Storage Server Solution Earns Government Recognition TAIPEI, Taiwan–(BUSINESS WIRE)–#datamanagement–Phison Electronics (8299TT), a leading provider of NAND controllers and NAND storage solutions, today (December 24, 2025) announced its participation in the inaugural International FHIR Server Performance Competition hosted by Taiwan’s Ministry of Health and Welfare (MOHW). Leveraging its self-developed, on-premises high-performance storage server solution, … [Read more…]

TORONTO–(BUSINESS WIRE)–Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQB: MVMDF) (FRA: 20MP) provides a year-end business update on its commercialization progress across its three core areas of focus: Nutraceuticals – Innovations through the Company’s Quicksome™ technology, designed to improve the administration and efficacy of nutraceutical health and wellness products; Agriculture – … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “X-Ray Inspection System Market – Global Forecast 2025-2032” has been added to ResearchAndMarkets.com’s offering. Market research reveals the X-Ray Inspection System Market is poised for significant growth, projected to increase from USD 1.63 billion in 2024 to USD 2.59 billion by 2032 at a CAGR of 5.96%. As quality control and safety standards … [Read more…]

– Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET –  First and only approved option: YARTEMLEA® is the only approved treatment for hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA) and is indicated for adults and children ages two years and older. High complete response (CR) rates: YARTEMLEA-treated patients achieved CR … [Read more…]

CAMBRIDGE, Mass. & MONTREAL–(BUSINESS WIRE)–Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a clinical-stage precision oncology company, today announced a definitive asset purchase agreement for Gilead Sciences, Inc. to acquire Repare’s polymerase theta (Polθ) ATPase inhibitor, RP-3467 (the “Gilead Agreement”). “We are pleased to announce this transaction which combines Gilead’s leading expertise in oncology … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies based on its proprietary Tumor Activated T Cell Engager (TRACTr), Tumor Activated Immunomodulator (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms, today provided a program update on its ongoing Phase 1 study evaluating JANX008, its EGFR-targeted … [Read more…]

PLANTATION, Fla.–(BUSINESS WIRE)–Akumin Inc. (together with its subsidiaries “Akumin” or the “Company”) announced today that it entered into an agreement (the “Support Agreement”) with certain noteholders representing over 95% of outstanding senior secured notes due in 2027 and 2028 (together, the “Senior Secured Notes”), and Stonepeak, a leading alternative investment firm, that will reduce debt, … [Read more…]

Deseyne® (vifilcon C) Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia with Extended Depth of Focus (EDOF) Delivers Continuous Vision at All Distances—Redefining Presbyopia Correction BOCA RATON, Fla.–(BUSINESS WIRE)–The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Over The Counter Drugs Market – Global Forecast 2025-2032” report has been added to ResearchAndMarkets.com’s offering. The Over The Counter Drugs Market is experiencing fundamental shifts as self-care gains traction across healthcare models. Senior leaders face complex choices as digitalization, regulatory adjustments, and evolving consumer behaviors redefine sector dynamics and competitive priorities. Market … [Read more…]